Press Resease

Diagnostic Specialty Enzyme Market - by Product (Protease, Polymerases, Lipase, and Carbohydrases), and Application (Immunoassays, Clinical Chemistry, and Molecular Diagnostics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 24-Sep-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3628 Status : Published

According to the report published by Zion Market Research, global diagnostic specialty enzyme market was valued at approximately USD 780 Million in 2019, and is expected to generate revenue of around USD 1,240 Million by end of 2026, growing at a CAGR of around 8% between 2020 and 2026.

Description

According to the report published by Zion Market Research, global diagnostic specialty enzyme market was valued at approximately USD 780 Million in 2019, and is expected to generate revenue of around USD 1,240 Million by end of 2026, growing at a CAGR of around 8% between 2020 and 2026.

Global Diagnostic Specialty Enzyme Market: Overview

Diagnostic specialty enzymes find applications in low volume and high value-added applications. Major use of diagnostic specialty enzymes is in clinical chemistry, molecular diagnostics, and immunoassay. They help in reduction of systemic inflammation, enhancing muscle mass, making immune system stronger, and assist in breaking down as well as digesting food.

Global Diagnostic Specialty Enzyme Market: Growth Factors

Increase in biotech & diagnostic applications and rise in occurrence of chronic, infectious, and lifestyle diseases are anticipated to propel the growth of the global market from 2018 to 2026. The global diagnostic specialty enzymes market is driven by surge in investments, early as well as instantaneous diagnosis of life-threatening ailments, and rise in geriatric population in the developed countries. However, lack of customer education and adoption, and technical complex and niche nature are the major restraints of the global diagnostic specialty enzymes market. Nevertheless, the increase in the rate of the patients affected as a result of contagious ailments and other lifestyle related disorders will enhance the demand for diagnostic specialty enzymes market in the years to come.

Heavy funding of activities pertaining to biotechnology and genetics by pharmaceutical firms and rise in diagnostics testing with diminishing DNA sequencing costs resulting in massive testing of food, medical, and agricultural products will further propel diagnostic specialty enzymes market growth in the years ahead. In addition, huge investments made by leading Pharma firms to boost R&D activities related to biologics will further scale up the growth of diagnostic specialty enzymes market in the estimated timeline.

Global Diagnostic Specialty Enzyme Market: Segmentation

The global diagnostic specialty enzymes market can be divided based on product and application. Product wise, the diagnostic specialty enzymes market is segmented into Protease, polymerases, lipase, and carbohydrases. Based on the application, the market is sectored into immunoassays, clinical chemistry, and molecular diagnostics.

Global Diagnostic Specialty Enzyme Market: Regional Analysis

Based on regions, the global diagnostic specialty enzymes market can be divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America captured the largest share of the global diagnostic specialty enzymes market in 2017. Increase in acceptance of new biotechnology technologies such as next generation sequencing along with massive awareness and significant research spending in overall national budgets boosts the growth of the market in the U.S.

Asia Pacific is projected to acquire large market share during the forecast timeline and is likely to be the key region in terms of revenue in the next few years. Development of health care infrastructure, rise in population, growth of the biotechnology industry, and increase in burden of diseases necessitating diagnostics in Brazil, South Africa, Saudi Arabia, etc. are likely to propel the growth of the diagnostic specialty enzymes market in Latin America and Middle East & Africa.

Global Diagnostic Specialty Enzyme Market: Competitive Players

Some main participants of the diagnostic specialty enzyme market are Robert F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., Micogen, Inc., Amano Enzymes, Inc., Affymetrix, Inc. Thermo Fisher Scientific, Inc., American Laboratories, Inc. Amano Enzymes Inc., Biocatalysts Ltd., and Advanced Enzymes Technologies Ltd., BBI Solutions, among others.

Diagnostic Specialty Enzyme Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.1.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Diagnostic Specialty Enzymes Market, 2016 – 2026 (USD Million)
    • 3.2.Global Diagnostic Specialty Enzymes Market: Snapshot
  • Chapter 4.Diagnostic Specialty Enzymes Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Diagnostic Specialty Enzymes
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technology Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Diagnostic Specialty Enzymes Market Attractiveness, By Product
    • 5.2.Global Diagnostic Specialty Enzymes Market Attractiveness, By Application
    • 5.3.Global Diagnostic Specialty Enzymes Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Diagnostic Specialty Enzymes Market: Company Market Share, 2019
    • 6.2.Strategic Developments
    • 7.1.Global Diagnostic Specialty Enzymes Market Overview: by Product
      • 7.1.1.Global Diagnostic Specialty Enzymes Market Revenue Share, by Product, 2019 & 2026
    • 7.2.Global Diagnostic Specialty Enzymes Market Analysis/Overview – By Product
      • 7.2.1.Protease – Overview/Analysis
      • 7.2.2.Pulymerases – Overview/Analysis
      • 7.2.3.Lipase – Overview/Analysis
      • 7.2.4.Darbohydrases – Overview/Analysis
    • 7.3.Protease
      • 7.3.1.Global Diagnostic Specialty Enzymes Market for Protease, Revenue (USD Million) 2016 - 2026
    • 7.4.Pulymerases
      • 7.4.1.Global Diagnostic Specialty Enzymes Market for Pulymerases, Revenue (USD Million) 2016 - 2026
    • 7.5.Lipase
      • 7.5.1.Global Diagnostic Specialty Enzymes Market for Lipase, Revenue (USD Million) 2016 - 2026
    • 7.6.Darbohydrases
      • 7.6.1.Global Diagnostic Specialty Enzymes Market for Darbohydrases, Revenue (USD Million) 2016 - 2026
    • 8.1.Global Diagnostic Specialty Enzymes Market Overview: by Application
      • 8.1.1.Global Diagnostic Specialty Enzymes Market Revenue Share, by Application, 2019 & 2026
    • 8.2.Global Diagnostic Specialty Enzymes Market Analysis/Overview – By Application
      • 8.2.1.Immunoassays – Overview/Analysis
      • 8.2.2.Clinical Chemistry – Overview/Analysis
      • 8.2.3.Molecular Diagnostics – Overview/Analysis
    • 8.3.Immunoassays
      • 8.3.1.Global Diagnostic Specialty Enzymes Market for Immunoassays, Revenue (USD Million) 2016 - 2026
    • 8.4.Clinical Chemistry
      • 8.4.1.Global Diagnostic Specialty Enzymes Market for Clinical Chemistry, Revenue (USD Million) 2016 - 2026
    • 8.5.Molecular Diagnostics
      • 8.5.1.Global Diagnostic Specialty Enzymes Market for Molecular Diagnostics, Revenue (USD Million) 2016 - 2026
  • Chapter 9.Diagnostic Specialty Enzymes Market – Regional Analysis
    • 9.1.Global Diagnostic Specialty Enzymes Market: Regional Overview
      • 9.1.1.Global Diagnostic Specialty Enzymes Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2.Global Diagnostic Specialty Enzymes Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 9.2.North America
      • 9.2.1.North America Diagnostic Specialty Enzymes Market Revenue, 2016 - 2026 (USD Million)
      • 9.2.2.North America Diagnostic Specialty Enzymes Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.2.3.North America Diagnostic Specialty Enzymes Market Revenue, by Product, 2016 – 2026
      • 9.2.4.North America Diagnostic Specialty Enzymes Market Revenue, by Application, 2016 – 2026
      • 9.2.5.U.S.
      • 9.2.6.Canada
    • 9.3.Europe
      • 9.3.1.Europe Diagnostic Specialty Enzymes Market Revenue, 2016 - 2026 (USD Million)
      • 9.3.2.Europe Diagnostic Specialty Enzymes Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.3.3.Europe Diagnostic Specialty Enzymes Market Revenue, by Product, 2016 – 2026
      • 9.3.4.Europe Diagnostic Specialty Enzymes Market Revenue, by Application, 2016 – 2026
      • 9.3.5.Germany
      • 9.3.6.France
      • 9.3.7.U.K.
      • 9.3.8.Italy
      • 9.3.9.Spain
      • 9.3.10.Rest of Europe
    • 9.4.Asia Pacific
      • 9.4.1.Asia Pacific Diagnostic Specialty Enzymes Market Revenue, 2016 - 2026 (USD Million)
      • 9.4.2.Asia Pacific Diagnostic Specialty Enzymes Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.4.3.Asia Pacific Diagnostic Specialty Enzymes Market Revenue, by Product, 2016 – 2026
      • 9.4.4.Asia Pacific Diagnostic Specialty Enzymes Market Revenue, by Application, 2016 – 2026
      • 9.4.5.China
      • 9.4.6.Japan
      • 9.4.7.India
      • 9.4.8.South Korea
      • 9.4.9.South-East Asia
      • 9.4.10.Rest of Asia Pacific
    • 9.5.Latin America
      • 9.5.1.Latin America Diagnostic Specialty Enzymes Market Revenue, 2016 - 2026 (USD Million)
      • 9.5.2.Latin America Diagnostic Specialty Enzymes Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.5.3.Latin America Diagnostic Specialty Enzymes Market Revenue, by Product, 2016 – 2026
      • 9.5.4.Latin America Diagnostic Specialty Enzymes Market Revenue, by Application, 2016 – 2026
      • 9.5.5.Brazil
      • 9.5.6.Mexico
      • 9.5.7.Rest of Latin America
    • 9.6.The Middle-East and Africa
      • 9.6.1.The Middle-East and Africa Diagnostic Specialty Enzymes Market Revenue, 2016 - 2026 (USD Million)
      • 9.6.2.The Middle-East and Africa Diagnostic Specialty Enzymes Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.6.3.The Middle-East and Africa Diagnostic Specialty Enzymes Market Revenue, by Product, 2016 – 2026
      • 9.6.4.The Middle-East and Africa Diagnostic Specialty Enzymes Market Revenue, by Application, 2016 – 2026
      • 9.6.5.GCC Countries
      • 9.6.6.South Africa
      • 9.6.7.Rest of Middle-East Africa
  • Chapter 10.Company Profiles
    • 10.1.F. Hoffmann-La Roche Ltd.
      • 10.1.1.Company Overview
      • 10.1.2.Financial Overview
      • 10.1.3.Product Portfolio
      • 10.1.4.Business Strategy
      • 10.1.5.Recent Developments
    • 10.2.Novozymes A/S
    • 10.3.Codexis Inc.
    • 10.4.Micogen Inc.
    • 10.5.Amano Enzymes Inc.
    • 10.6.Affymetrix Inc.
    • 10.7.Thermo Fisher Scientific, Inc.
    • 10.8.American Laboratories, Inc.
    • 10.9.Amano Enzymes Inc.
    • 10.1.Biocatalysts Ltd.
    • 10.11.Advanced Enzymes Technologies Ltd.
    • 10.12.BBI Sulutions

Methodology


Frequently Asked Questions

One of the primary growth driving factor of the diagnostic specialty enzyme market is increasing prevalence of chronic and infectious diseases in urban parts. Further, investment in biotechnology and genetics by pharmaceutical firms has also played a vital role in fuelling the market growth.

According to the report published by Zion Market Research, global diagnostic specialty enzyme market was valued at approximately USD 780 Billion in 2019, and is expected to generate revenue of around USD 1,240 Million by end of 2026, growing at a CAGR of around 8% between 2020 and 2026.

The Asia Pacific diagnostic specialty enzyme market is projected to hold the largest share globally in the future. Soaring health care infrastructure and growing population has led to increasing consumption of diagnostic specialty enzyme, which has driven the Asia Pacific diagnostic specialty enzyme market.

Some main participants of the diagnostic specialty enzyme market are Robert F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., Micogen, Inc., Amano Enzymes, Inc., Affymetrix, Inc. Thermo Fisher Scientific, Inc., American Laboratories, Inc. Amano Enzymes Inc., Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., and BBI Solutions,

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com